Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat doses of RV6153 in asthma patients and healthy v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• RV6153

Snippet

Sponsor: Respivert Ltd | Conditions: Asthma, Healthy Volunteers | Phase 1 | Status: TERMINATED